Harbajan Chadha‐Boreham
Harbajan Chadha‐Boreham publishes mostly in Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Physiology, on topics such as Systemic Sclerosis and Related Diseases, Lysosomal Storage Disorders Research and Pulmonary Hypertension Research and Treatments.
- World rank
- #944,061 of 7,710,434 ranked researchers
- Rank in Switzerland
- #16,370 of 80,918
- Works
- 33
- Citations
- 2.3k
- Citations per work
- 69.0
What does Harbajan Chadha‐Boreham research?
Harbajan Chadha‐Boreham's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1544.8%
- Medicine1544.8%
- Everything else1340.3%
- Life Sciences514.9%
- 1Pathology and Forensic Medicine15% of their works
- 2Pulmonary and Respiratory Medicine14% of their works
- 3Physiology9% of their works
- 4Genetics8% of their works
- 5Endocrinology, Diabetes and Metabolism7% of their works
- 6Molecular Biology7% of their works
Research topics
- Systemic Sclerosis and Related Diseases
- Lysosomal Storage Disorders Research
- Pulmonary Hypertension Research and Treatments
- Estrogen and related hormone effects
- Menopause: Health Impacts and Treatments
- Child Nutrition and Feeding Issues
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Connective Tissue Growth Factor Research
Which keywords describe Harbajan Chadha‐Boreham's research?
The keywords of their largest research topics: Endothelial Dysfunction, Fibrosis, TGF-ß Signaling, Autoantibodies, Systemic Sclerosis, Breast Cancer, Estrogen and Enzyme Replacement Therapy.
- CCN Family
- Interstitial Lung Disease
- Hormone Therapy
- Autism Spectrum Disorders
- Receptor
- Pulmonary Hypertension
- Enzyme Replacement Therapy
- Breast Cancer
- Autoantibodies
- Fibrosis
- Endothelial Dysfunction
- TGF-ß Signaling
- Systemic Sclerosis
- Estrogen
- Lysosomal Storage Disorders
- Right Heart Assessment
- Signaling
- Feeding Problems
- Idiopathic Pulmonary Fibrosis
- Menopause
- Connective Tissue Growth Factor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Endothelial Dysfunction192 topics
- Fibrosis183 topics
- TGF-ß Signaling142 topics
- Autoantibodies111 topic
- Systemic Sclerosis111 topic
- Breast Cancer92 topics
- Estrogen92 topics
- Enzyme Replacement Therapy81 topic
- Lysosomal Storage Disorders81 topic
- Pulmonary Hypertension81 topic
- Right Heart Assessment81 topic
- Receptor51 topic
- Signaling51 topic
- Autism Spectrum Disorders41 topic
- Feeding Problems41 topic
- Hormone Therapy41 topic
- Idiopathic Pulmonary Fibrosis41 topic
- Interstitial Lung Disease41 topic
- Menopause41 topic
- CCN Family31 topic
- Connective Tissue Growth Factor31 topic
Where does Harbajan Chadha‐Boreham work?
Harbajan Chadha‐Boreham's main affiliation in the publication record is Actelion (Switzerland), Switzerland.
How many publications and citations does Harbajan Chadha‐Boreham have?
OpenAlex counts 33 works and 2,276 citations for Harbajan Chadha‐Boreham, an h-index of 16, ranking #944,061 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Harbajan Chadha‐Boreham. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.